Remy Villette

Remy Villette

Auto-generated profile, based on publicly available information

Remy Villette

Luxembourg Centre for Systems Biomedicine, University of Luxembourg

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
RVRemy Villette
Remy Villette
PKPukar KC
Pukar KC
SBSophie Beliard
Sophie Beliard
MTMaria Fernanda Salas Tapia
Maria Fernanda Salas Tapia
DRDominique Rainteau
Dominique Rainteau
PLPhilippe Lesnik
Philippe Lesnik
Disruption in cholesterol metabolism, particularly hypercholesterolemia, is a significant cause of atherosclerotic cardiovascular disease. Large interindividual variations in plasma cholesterol levels are traditionally related to genetic factors, and the remaining portion of their variance is accredited to environmental factors. In recent years, the essential role played by intestinal microbiota in human health and diseases has emerged. The gut microbiota is currently viewed as a fundamental regulator of host metabolism and of innate and adaptive immunity. Its bacterial composition but also the synthesis of multiple molecules resulting from bacterial metabolism vary according to diet, antibiotics, drugs used, and exposure to pollutants and infectious agents. Microbiota modifications induced by recent changes in the human environment thus seem to be a major factor in the current epidemic of metabolic/inflammatory diseases (diabetes mellitus, liver diseases, inflammatory bowel disease, obesity, and dyslipidemia). Epidemiological and preclinical studies report associations between bacterial communities and cholesterolemia. However, such an association remains poorly investigated and characterized. The objectives of this review are to present the current knowledge on and potential mechanisms underlying the host-microbiota dialogue for a better understanding of the contribution of microbial communities to the regulation of cholesterol homeostasis.

3 October 2025 in Science Advances
Verified
Journal Article
Open access
MHMorgane Hilaire
Morgane Hilaire
AMAngélina Mimoun
Angélina Mimoun
LCLéonie Cagnet
Léonie Cagnet
RVRémy Villette
Rémy Villette
ARAristeidis Roubanis
Aristeidis Roubanis
BSBenoît L. Salomon
Benoît L. Salomon
Foxp3 + regulatory T cells (T regs ) reside in both lymphoid and nonlymphoid organs, where they play a crucial role in immune tolerance and tissue homeostasis. In mice, T regs begin colonizing these tissues shortly after birth, contributing to long-term immune response regulation therein. However, the kinetics of T reg generation across different tissues remains unclear. Here, we investigate T reg ontogeny from birth to adulthood in various tissues. In lymphoid organs, the adult T reg pool is continuously replenished with cells generated at different ages. In contrast, the skin retains a large fraction of T regs that colonize the tissue during the neonatal period, with minimal turnover in adulthood. The liver, lungs, and colon exhibit intermediate T reg renewal dynamics. Notably, neonatal T regs that persist into adulthood display a more activated phenotype and express markers associated with tissue-resident T regs and type 2 immunity. Our findings reveal tissue-specific differences in T reg generation kinetics and highlight a major phenotypic shift between neonatal and adult-derived T regs .

24 March 2026 in View
Verified
Journal Article
Open access
CRCharlotte De Rudder
Charlotte De Rudder
KGKacy Greenhalgh
Kacy Greenhalgh
JBJoanna Baginska
Joanna Baginska
CMCamille Martin‐Gallausiaux
Camille Martin‐Gallausiaux
LGLéa Grandmougin
Léa Grandmougin
PWPaul Wilmes
Paul Wilmes
An individual's immune status is an essential factor affecting the efficacy of microbiome‐based therapies. To enable representative studies of microbiome–immune system interactions, we developed protocols to facilitate the coculture of intestinal epithelial cells and human peripheral blood mononuclear cells (PBMCs) in our microphysiological model of the human gut, HuMiX. Using the resulting immunoHuMiX model, we assessed responses to human–microbial cocultures with a probiotic mixture comprised of 17 strictly anaerobic Clostridial strains (17‐mix). We demonstrated the ability of our model to sustain metabolically active microbiota, while maintaining human cell viability, and generated relevant read‐outs for host–microbiome interaction studies. The composition of the strain mixture was not affected by the individual sources of PBMCs, and the abundances of the different immune cell populations were comparable when incubated with or without the 17‐mix after 24 h in the system, and between individuals. We observed increased cytokine production, PBMC viability, and PBMC cell counts upon coculture with the 17‐mix, thereby demonstrating immune sensing of the microbiota by the PBMCs. In summary, our immunoHuMiX model provides an important personalizable tool for screening microbiota‐driven immune responses.

17 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
RVRemy Villette
Remy Villette
JSJúlia Ortís Sunyer
Júlia Ortís Sunyer
PNPolina Novikova
Polina Novikova
VAVelma T. E. Aho
Velma T. E. Aho
VPVyacheslav Petrov
Vyacheslav Petrov
PWPaul Wilmes
Paul Wilmes
Summary: Parkinson’s disease (PD) is associated with gut microbiome shifts, but the functional consequences remain unclear. Here, we use an integrated multi-omics approach to compare the gut microbiomes of individuals with PD and prodromal PD as well as healthy individuals. After analyzing each omics, meta-metabolomic was selected to inform the analysis as it represents the most discriminatory and robust ome. We identified 11 metabolites that were differentially abundant between the groups, amongst which β-glutamate was increased in PD and prodromal PD, and correlated with the transcriptional activities of Methanobrevibacter smithii and Clostridium spp. We identified decreases in transcripts, but not in gene abundances, related to glutamate metabolism, bile acids, chemotaxis and flagellar assembly in PD, particularly in keystone genera such as Roseburia, Agathobacter and Blautia . Our findings, integrated into the Expobiome map, reveal multifactorial microbiome alterations which converge with PD pathways. Our study highlights the importance of investigating the gut microbiome’s functional dimensions to better resolve microbiome-host interactions in health and disease.

28 April 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
RVRemy Villette
Remy Villette
DTDjelika Traore
Djelika Traore
EDElise Dhilly
Elise Dhilly
PFPierre Foucault
Pierre Foucault
EPEleonore Parisel
Eleonore Parisel
EGEarlyFOOD study group
EarlyFOOD study group
Summary: The gut microbiota of 2-3 month-old infants is associated with later pre-allergic signs, while the microbiota at the time of allergic manifestation is not. We hypothesized that the infant gut microbiota and immune system are primed shortly after birth, and that this is influenced by maternal transfer of humoral immunity. We investigated the association between allergic outcomes and composition and humoral immunity to gut microbiota at birth, 2 months, and 2 years-of-age. Meconium microbiota clustered into three groups dominated by Escherichia , Enterococcus , and mixed genera, respectively. The Escherichia cluster was associated with protection against later allergic manifestations. We moreover studied the proportion and specificity of humoral immunity to gut microbiota. Humoral immunity to gut microbiota at birth was associated with future allergies. Future studies should evaluate whether interventions to alter gut microbiota and humoral immunity in early-life protects against allergy.

30 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
RVRemy Villette
Remy Villette
PNPolina Novikova
Polina Novikova
CLCedric Laczny
Cedric Laczny
BMBrit Brit Mollenhauer
Brit Brit Mollenhauer
Patrick MayPatrick May
Patrick May
PWPaul Wilmes
Paul Wilmes
Alterations of gut microbiome structure have been observed in a panoply of human diseases including neurodegeneration. However, the ecological and functional deficits of microbiome dysbiosis have yet to be understood. Here, using integrated multi-omics (metagenomics and metatranscriptomics), we resolve microbiome gene co-expression networks in individuals with Parkinson′s disease (PD) and healthy individuals. We uncover network modules with high closeness and degree centrality that represent core ecological functions, and identify key features lost in PD. More specifically, we observe a significant depletion in specific functions including secondary bile acid biosynthesis and flagellar assembly (FA) in PD. Strikingly, most hub genes, particularly those involved in bacterial microcompartments (BMCs) and FA, are predominantly found in healthy individuals. Blautia and Anaerobutyricum genera are the main contributors to these functions, showing significantly lower expression of BMC genes in PD. Additionally, we identify a strong correlation between the expression of BMC and FA genes, but also an apparent dysregulation in cross feeding between commensals in PD. Importantly, gene expression in PD was tied to reduced diversity in expressed genes, whereas in healthy individuals, higher expression levels were linked to higher diversity. Our findings reveal disruptions in key gut metabolic functions at both functional and taxonomic levels, potentially driving disease progression. Notably, we identify crucial microbiome-wide ecological features that should be restored in future gut microbiome rewilding efforts.